Endoscopy Global Market – Forecast To 2020
Endoscopy is a minimal invasive procedure to view the internal organs of the body. Endoscopic procedures are used to retrieve samples for biopsies, to remove foreign objects inside the body and to perform keyhole surgeries. The global endoscopy market is classified by product and application types. Rigid, flexible, capsule and video endoscopes are the major types of endoscope products. Depending on the medical applications the market is segmented into arthroscopy, colonoscopy, laparoscopy, gastro intestinal endoscopy, bronchoscopy, Urology endoscopy, and gynecology endoscopy.
The global endoscopy market is expected to reach approximately $47 billion by 2020 growing at around 7.0% CAGR from 2014 to 2020. The major drivers for the market growth are aging population, increase in cancer, diabetes, and obesity patients along with a rise in patient’s preference for minimal invasive surgeries. Additionally, shorter stay in hospitals, speedy recovery, and reduced medical budget enhance the growth of the market. However, the shortage of qualified endoscopic technicians, high cost of initial investment, contamination risk and patient safety of endoscopic procedures pose a threat for the market growth.
Advancement in the field of endoscopic devices with accurate visibility, high definition imaging and documentation, ease of handling and cleaning the devices and growing demand in emerging countries brings in more opportunities for the endoscopy market.
The global endoscopy devices products market is segmented into endoscopes, visualization and documentation systems, endoscopic accessories and services. The endoscopes segment commanded the largest market in 2013 and is expected to grow strong by 2020. The visualization and documentation system is expected to grow at the highest CAGR of nearly 10.0% during the forecast period. Among the applications segment Laparoscopic application segment holds the largest market in 2013 and Neurology application segment is expected to grow at the highest CAGR of more than 10% during the forecast period.
North America accounts for the largest market share with increase in endoscopic treatment options and obese population followed by Europe and Japan. Although U.S. has a high market share, there is a growing demand for endoscopy market in the emerging countries such as India and China. Along with an increase in medical spending, improvement in medical infrastructure and changes in life style attribute to the growth of the market in emerging countries.
The global endoscopy market is expected to reach approximately $47 billion by 2020 growing at around 7.0% CAGR from 2014 to 2020. The major drivers for the market growth are aging population, increase in cancer, diabetes, and obesity patients along with a rise in patient’s preference for minimal invasive surgeries. Additionally, shorter stay in hospitals, speedy recovery, and reduced medical budget enhance the growth of the market. However, the shortage of qualified endoscopic technicians, high cost of initial investment, contamination risk and patient safety of endoscopic procedures pose a threat for the market growth.
Advancement in the field of endoscopic devices with accurate visibility, high definition imaging and documentation, ease of handling and cleaning the devices and growing demand in emerging countries brings in more opportunities for the endoscopy market.
The global endoscopy devices products market is segmented into endoscopes, visualization and documentation systems, endoscopic accessories and services. The endoscopes segment commanded the largest market in 2013 and is expected to grow strong by 2020. The visualization and documentation system is expected to grow at the highest CAGR of nearly 10.0% during the forecast period. Among the applications segment Laparoscopic application segment holds the largest market in 2013 and Neurology application segment is expected to grow at the highest CAGR of more than 10% during the forecast period.
North America accounts for the largest market share with increase in endoscopic treatment options and obese population followed by Europe and Japan. Although U.S. has a high market share, there is a growing demand for endoscopy market in the emerging countries such as India and China. Along with an increase in medical spending, improvement in medical infrastructure and changes in life style attribute to the growth of the market in emerging countries.
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing demand for minimal invasive surgeries leading to fast recovery and reduced hospital stays
3.3.1.2 Rising aged cohort and life threatening diseases
3.3.1.3 Emerging applications and technological innovations
3.3.1.4 Increasing recognition of technology in emerging market
3.3.1.5 Increasing trend for integrated high-resolution technologies such as 3d systems, capsule endoscopes, and miniaturized endoscopy systems
3.3.1.6 Increasing number of obesity people preferring gastrointestinal endoscopy for weight loss
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Shortage of qualified endoscopic technicians
3.3.2.2 High investment cost for endoscopic equipment
3.3.2.3 Contamination risk associated with endoscopy procedures
3.4 TECHNOLOGICAL ADVANCEMENTS
3.4.1 NARROW BAND IMAGING (NBI)
3.4.2 HIGH DEFINITION IMAGING (HDI)
3.4.3 THIRD EYE RETROSCOPE
3.4.4 DOUBLE BALLOON ENDOSCOPY
3.4.5 PILLCAM
3.4.6 ROBOT ASSISTED ENDOSCOPY
3.4.7 NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY TECHNIQUE (NOTES)
3.4.8 PERORAL ENDOSCOPIC MYOTOMY (POEM)
3.4.9 ENDOSCOPIC ULTRASONOGRAPHY (EUS)-GUIDED THERAPY
3.4.10 ENDOBILIARY RADIOFREQUENCY ABLATION (RFA)
3.5 UPCOMING TECHNOLOGIES
3.6 REGULATORY AFFAIRS
3.6.1 U.S.
3.6.2 EUROPE
3.6.3 INDIA
3.6.4 CHINA
3.6.5 JAPAN
3.7 REIMBURSEMENT SCENERIO
3.7.1 GENERAL ENDOSCOPIC PROCEDURES:
3.7.2 CAPSULE ENDOSCOPY PROCEDURES:
3.7.3 ROBOT ASSISTED ENDOSCOPIC PROCEDURES:
3.7.4 REIMBURSEMENT SCENARIO IN DIFFERENT GEOGRAPHIES:
3.7.5 REIMBURSEMENT Table
3.8 PORTER’S FIVE FORCE ANALYSIS
3.8.1 THREAT OF NEW ENTRANTS
3.8.2 THREAT OF SUBSTITUTES
3.8.3 RIVALRY AMONG EXISTING COMPETITORS
3.8.4 BARGAINING POWER OF SUPPLIERS
3.8.5 BARGAINING POWER OF BUYERS
3.9 MARKET SHARE ANALYSIS BY KEY PLAYERS
4 ENDOSCOPY DEVICES GLOBAL MARKET, BY APPLICATION
4.1 INTRODUCTION
4.2 ARTHROSCOPY
4.2.1 INTRODUCTION
4.2.2 KNEE ARTHROSCOPY
4.2.3 SHOULDER ARTHROSCOPY
4.2.4 WRIST ARTHROSCOPY
4.2.5 ANKLE ARTHROSCOPY
4.2.6 ELBOW ARTHROSCOPY
4.2.7 HIP ARTHROSCOPY
4.3 BRONCHOSCOPY
4.4 CARDIO-PULMONARY
4.5 COLONOSCOPY
4.6 ENT ENDOSCOPY
4.6.1 INTRODUCTION
4.6.2 NASAL SINOSCOPY
4.6.3 LARYNGOSCOPY
4.6.4 OTOENDOSCOPY
4.6.5 TRANSNASAL ENDOSCOPY
4.6.6 THORACOSCOPY
4.7 GASTROINTESTINAL ENDOSCOPY
4.7.1 INTRODUCTION
4.7.2 UPPER GI ENDOSCOPY
4.7.3 DOUBLE BALLOON ENDOSCOPY
4.7.4 CAPSULE ENDOSCOPY
4.7.5 ENDOSCOPIC ULTRASOUND SURGERY (EUS)
4.7.6 ENDOSCOPIC MUCOSAL RESECTION(EMR)
4.7.7 CHROMOENDOSCOPY
4.7.8 NARROW BAND IMAGING (NBI)
4.8 GYNAECOLOGY/OBSTETRICS
4.8.1 INTRODUCTION
4.8.2 TUBAL STERILIZATION/LIGATION AND TREATMENT OF ECTOPIC PREGNANCY
4.8.3 LYSIS OF ADHESION
4.8.4 ENDOMETRIOSIS TREATMENT
4.8.5 HYSTERECTOMY & OVARIAN CYSTECTOMY
4.9 LAPAROSCOPY
4.9.1 INTRODUCTION
4.9.2 BARIATRIC SURGERY
4.9.3 CHOLECYSTECTOMY
4.9.4 APPENDECTOMY
4.9.5 HERNIA REPAIR
4.9.6 HAND ASSISTED LAPAROSCOPY
4.9.7 OTHERS
4.10 NEUROENDOSCOPY
4.10.1 INTRODUCTION
4.10.2 HYDROCEPHALUS
4.10.3 COLLOID CYST REMOVAL
4.10.4 ARACHNOID CYST FENESTRATION
4.10.5 NEUROCYSTICERCOSIS
4.10.6 SPINAL ENDOSCOPY
4.10.7 ENDOSCOPIC ASSISTED SURGERIES
4.11 UROLOGY
4.11.1 INTRODUCTION
4.11.2 NEPHROSCOPY
4.11.3 CYSTOSCOPY
4.11.4 RESECTOSCOPY
5 ENDOSCOPY MARKET, BY PRODUCTS
5.1 INTRODUCTION
5.2 ENDOSCOPES
5.2.1 RIGID ENDOSCOPES
5.2.2 FLEXIBLE ENDOSCOPES
5.2.3 ROBOT ASSISTED ENDOSCOPES
5.2.4 CAPSULE ENDOSCOPES
5.3 VISUALIZATION AND DOCUMENTATION SYSTEMS
5.3.1 INTRODUCTION
5.3.2 ENDOSCOPIC CAMERAS
5.3.3 DIGITAL DOCUMENTATION SYSTEMS
5.3.4 LIGHT SOURCES
5.3.5 MONITORS AND DISPLAY SYSTEMS
5.3.6 VIDEO CONVERTERS AND PROCESSORS
5.3.7 FLUID MANAGEMENT SYSTEMS
5.4 ENDOSCOPIC ACCESSORIES
5.5 SERVICING
6 REGIONAL MARKET ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.3 EUROPE
6.4 ASIA PACIFIC
6.5 REST OF THE WORLD (ROW)
7 COMPANY DEVELOPMENTS
7.1 INTRODUCTION
7.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF ENDOSCOPY DEVICES PLAYERS
7.2 NEW PRODUCT LAUNCH
7.3 MERGERS AND ACQUISITIONS
7.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
7.5 APPROVALS
7.6 OTHER DEVELOPMENTS
8 MAJOR PLAYER PROFILES
8.1 BOSTON SCIENTIFIC CORPOARTION
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 CONMED CORPORATION
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 COVIDIEN PLC
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 ETHICON ENDO-SURGERY, INC.
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 FUJIFILM HOLDINGS CORPORATION
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 HOYA CORPORATION
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 KARL STORZ GMBH & CO. KG
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 OLYMPUS CORPORATION
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 SMITH & NEPHEW PLC
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 STRYKER CORPORATION
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGIES
8.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing demand for minimal invasive surgeries leading to fast recovery and reduced hospital stays
3.3.1.2 Rising aged cohort and life threatening diseases
3.3.1.3 Emerging applications and technological innovations
3.3.1.4 Increasing recognition of technology in emerging market
3.3.1.5 Increasing trend for integrated high-resolution technologies such as 3d systems, capsule endoscopes, and miniaturized endoscopy systems
3.3.1.6 Increasing number of obesity people preferring gastrointestinal endoscopy for weight loss
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Shortage of qualified endoscopic technicians
3.3.2.2 High investment cost for endoscopic equipment
3.3.2.3 Contamination risk associated with endoscopy procedures
3.4 TECHNOLOGICAL ADVANCEMENTS
3.4.1 NARROW BAND IMAGING (NBI)
3.4.2 HIGH DEFINITION IMAGING (HDI)
3.4.3 THIRD EYE RETROSCOPE
3.4.4 DOUBLE BALLOON ENDOSCOPY
3.4.5 PILLCAM
3.4.6 ROBOT ASSISTED ENDOSCOPY
3.4.7 NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY TECHNIQUE (NOTES)
3.4.8 PERORAL ENDOSCOPIC MYOTOMY (POEM)
3.4.9 ENDOSCOPIC ULTRASONOGRAPHY (EUS)-GUIDED THERAPY
3.4.10 ENDOBILIARY RADIOFREQUENCY ABLATION (RFA)
3.5 UPCOMING TECHNOLOGIES
3.6 REGULATORY AFFAIRS
3.6.1 U.S.
3.6.2 EUROPE
3.6.3 INDIA
3.6.4 CHINA
3.6.5 JAPAN
3.7 REIMBURSEMENT SCENERIO
3.7.1 GENERAL ENDOSCOPIC PROCEDURES:
3.7.2 CAPSULE ENDOSCOPY PROCEDURES:
3.7.3 ROBOT ASSISTED ENDOSCOPIC PROCEDURES:
3.7.4 REIMBURSEMENT SCENARIO IN DIFFERENT GEOGRAPHIES:
3.7.5 REIMBURSEMENT Table
3.8 PORTER’S FIVE FORCE ANALYSIS
3.8.1 THREAT OF NEW ENTRANTS
3.8.2 THREAT OF SUBSTITUTES
3.8.3 RIVALRY AMONG EXISTING COMPETITORS
3.8.4 BARGAINING POWER OF SUPPLIERS
3.8.5 BARGAINING POWER OF BUYERS
3.9 MARKET SHARE ANALYSIS BY KEY PLAYERS
4 ENDOSCOPY DEVICES GLOBAL MARKET, BY APPLICATION
4.1 INTRODUCTION
4.2 ARTHROSCOPY
4.2.1 INTRODUCTION
4.2.2 KNEE ARTHROSCOPY
4.2.3 SHOULDER ARTHROSCOPY
4.2.4 WRIST ARTHROSCOPY
4.2.5 ANKLE ARTHROSCOPY
4.2.6 ELBOW ARTHROSCOPY
4.2.7 HIP ARTHROSCOPY
4.3 BRONCHOSCOPY
4.4 CARDIO-PULMONARY
4.5 COLONOSCOPY
4.6 ENT ENDOSCOPY
4.6.1 INTRODUCTION
4.6.2 NASAL SINOSCOPY
4.6.3 LARYNGOSCOPY
4.6.4 OTOENDOSCOPY
4.6.5 TRANSNASAL ENDOSCOPY
4.6.6 THORACOSCOPY
4.7 GASTROINTESTINAL ENDOSCOPY
4.7.1 INTRODUCTION
4.7.2 UPPER GI ENDOSCOPY
4.7.3 DOUBLE BALLOON ENDOSCOPY
4.7.4 CAPSULE ENDOSCOPY
4.7.5 ENDOSCOPIC ULTRASOUND SURGERY (EUS)
4.7.6 ENDOSCOPIC MUCOSAL RESECTION(EMR)
4.7.7 CHROMOENDOSCOPY
4.7.8 NARROW BAND IMAGING (NBI)
4.8 GYNAECOLOGY/OBSTETRICS
4.8.1 INTRODUCTION
4.8.2 TUBAL STERILIZATION/LIGATION AND TREATMENT OF ECTOPIC PREGNANCY
4.8.3 LYSIS OF ADHESION
4.8.4 ENDOMETRIOSIS TREATMENT
4.8.5 HYSTERECTOMY & OVARIAN CYSTECTOMY
4.9 LAPAROSCOPY
4.9.1 INTRODUCTION
4.9.2 BARIATRIC SURGERY
4.9.3 CHOLECYSTECTOMY
4.9.4 APPENDECTOMY
4.9.5 HERNIA REPAIR
4.9.6 HAND ASSISTED LAPAROSCOPY
4.9.7 OTHERS
4.10 NEUROENDOSCOPY
4.10.1 INTRODUCTION
4.10.2 HYDROCEPHALUS
4.10.3 COLLOID CYST REMOVAL
4.10.4 ARACHNOID CYST FENESTRATION
4.10.5 NEUROCYSTICERCOSIS
4.10.6 SPINAL ENDOSCOPY
4.10.7 ENDOSCOPIC ASSISTED SURGERIES
4.11 UROLOGY
4.11.1 INTRODUCTION
4.11.2 NEPHROSCOPY
4.11.3 CYSTOSCOPY
4.11.4 RESECTOSCOPY
5 ENDOSCOPY MARKET, BY PRODUCTS
5.1 INTRODUCTION
5.2 ENDOSCOPES
5.2.1 RIGID ENDOSCOPES
5.2.2 FLEXIBLE ENDOSCOPES
5.2.3 ROBOT ASSISTED ENDOSCOPES
5.2.4 CAPSULE ENDOSCOPES
5.3 VISUALIZATION AND DOCUMENTATION SYSTEMS
5.3.1 INTRODUCTION
5.3.2 ENDOSCOPIC CAMERAS
5.3.3 DIGITAL DOCUMENTATION SYSTEMS
5.3.4 LIGHT SOURCES
5.3.5 MONITORS AND DISPLAY SYSTEMS
5.3.6 VIDEO CONVERTERS AND PROCESSORS
5.3.7 FLUID MANAGEMENT SYSTEMS
5.4 ENDOSCOPIC ACCESSORIES
5.5 SERVICING
6 REGIONAL MARKET ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.3 EUROPE
6.4 ASIA PACIFIC
6.5 REST OF THE WORLD (ROW)
7 COMPANY DEVELOPMENTS
7.1 INTRODUCTION
7.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF ENDOSCOPY DEVICES PLAYERS
7.2 NEW PRODUCT LAUNCH
7.3 MERGERS AND ACQUISITIONS
7.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
7.5 APPROVALS
7.6 OTHER DEVELOPMENTS
8 MAJOR PLAYER PROFILES
8.1 BOSTON SCIENTIFIC CORPOARTION
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 CONMED CORPORATION
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 COVIDIEN PLC
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 ETHICON ENDO-SURGERY, INC.
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 FUJIFILM HOLDINGS CORPORATION
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 HOYA CORPORATION
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 KARL STORZ GMBH & CO. KG
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 OLYMPUS CORPORATION
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 SMITH & NEPHEW PLC
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 STRYKER CORPORATION
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGIES
8.10.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($BN)
Table 2 ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATIONS, (2012-2020) ($BN)
Table 3 ENDOSCOPY GLOBAL MARKET REVENUE, BY PRODUCTS, (2012-2020) ($BN)
Table 4 ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION, (2012-2020) ($BN)
Table 5 ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 6 ARTHROSCOPY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 7 ARTHROSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 8 KNEE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 9 SHOULDER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 10 WRIST ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 11 ANKLE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 12 ELBOW ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 13 HIP ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 14 BRONCHOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 15 CARDIO-PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 16 COLONOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 17 COLONOSCOPY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 18 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 19 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 20 NASAL SINOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 21 LARYNGOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 22 OTOENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 23 TRANSNASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 24 THORACOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 25 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 26 GASTROINTESTINAL ENDOSCOPY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 27 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 28 UPPER GI ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 29 DOUBLE BALLOON ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 30 CAPSULE ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 31 ENDOSCOPIC ULTRASOUND SURGERY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 32 ENDOSCOPIC MUCOSAL RESECTION GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 33 CHROMOENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 34 GI NARROW BAND IMAGING BASED ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 35 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 36 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 37 TUBAL LIGATION & ECTOPIC PREGNANCY RELATED ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 38 ENDOSCOPIC LYSIS OF ADHESION GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 39 ENDOSCOPIC ENDOMETRIOSIS TREATMENT GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 40 HYSTERECTOMY AND OVARIAN CYSTECTOMY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 41 LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 42 LAPAROSCOPY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 43 LAPAROSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 44 ENDOSCOPIC BARIATRIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 45 CHOLECYSTECTOMY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 46 APPENDECTOMY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 47 HERNIA REPAIR LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 48 HAND ASSISTED LAPAROSCOPIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 49 OTHER LAPAROSCOPIC GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 50 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 51 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 52 HYDROCEPHALUS NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 53 COLLIOD CYST REMOVAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 54 ARACHNOID CYST FENESTRATION NEUROENDOSCOPIC GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 55 NEUROCYSTICERCOSIS NEUROENDOSCOPIC GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 56 SPINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 57 NEUROENDOSCOPIC ASSISTED SURGERIES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 58 UROLOGY ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 59 UROLOGY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 60 UROLOGY ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 61 NEPHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 62 CYSTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 63 RESECTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 64 ENDOSCOPY GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 65 ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 66 ENDOSCOPES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 67 RIGID ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 68 FLEXIBLE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 69 ROBOT ASSISTED ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 70 CAPSULE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 71 VISUALIZATION AND DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 72 VISUALIZATION AND DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 73 ENDOSCOPIC CAMERAS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 74 DIGITAL DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 75 LIGHT SOURCES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 76 MONITORS AND DISPLAY SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 77 VIDEO CONVERTORS AND PROCESSORS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 78 FLUID MANAGEMENT SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 79 ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 80 ENDOSCOPY SERVICES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 81 GLOBAL ENDOSCOPY MARKET, BY REGION, (2012–2020) ($BN)
Table 82 ENDOSCOPY NORTH AMERICAN MARKET REVENUE, BY APPLICATION, (2012–2020) ($BN)
Table 83 ARTHROSCOPY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 84 LAPAROSCOPY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 85 UROLOGY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 86 ENT ENDOSCOPY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 87 GASTROINTESTENAL NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020)($BN)
Table 88 GYNECOLOGY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 89 NEUROLOGY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 90 ENDOSCOPY NORTH AMERICAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 91 ENDOSCOPES NORTH AMERICAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 92 VISUALIZATION AND DOCUMENTATION SYSTEMS NORTH AMERICAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 93 ENDOSCOPY EUROPEAN MARKET, REVENUE BY APPLICATION, (2012–2020) ($BN)
Table 94 ARTHROSCOPY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 95 LAPAROSCOPY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 96 UROLOGY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 97 ENT ENDOSCOPY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 98 GASTROINTESTENAL EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 99 GYNECOLOGY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 100 NEUROLOGY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 101 ENDOSCOPY EUROPEAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 102 ENDOSCOPES EUROPEAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 103 VISUALIZATION AND DOCUMENTATION SYSTEMS EUROPEAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 104 ENDOSCOPY APAC MARKET, REVENUE BY APPLICATION, (2012–2020) ($BN)
Table 105 ARTHROSCOPY APAC MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 106 LAPAROSCOPY APAC MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 107 UROLOGY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 108 ENT ENDOSCOPY APAC MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 109 GASTROINTESTENAL APAC MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 110 GYNECOLOGY APAC MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 111 NEUROLOGY APAC MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 112 ENDOSCOPY APAC MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 113 ENDOSCOPES APAC MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 114 VISUALIZATION AND DOCUMENTATION SYSTEMS APAC MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 115 ENDOSCOPY ROW MARKET, REVENUE BY APPLICATION, (2012–2020) ($BN)
Table 116 ARTHROSCOPY ROW MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 117 LAPAROSCOPY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 118 UROLOGY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 119 ENT ENDOSCOPY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 120 GASTROINTESTENAL ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 121 GYNAECOLOGY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 122 NEUROLOGY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 123 ENDOSCOPY ROW MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 124 ENDOSCOPES ROW MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 125 VISUALIZATION AND DOCUMENTATION SYSTEMS ROW MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 126 NEW PRODUCT LAUNCHES (2011-2014)
Table 127 MERGERS AND ACQUISITIONS (2011-2014)
Table 128 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2011-2014)
Table 129 APPROVALS, (2011-2014)
Table 130 OTHER DEVELOPMENTS (2011-2014)
Table 131 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 132 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN)
Table 133 BOSTON SCIENTIFIC CORPORATION: MEDICAL SURGERY BUSINESS REVENUE (2011-2013) ($MN)
Table 134 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 135 CONMED CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 136 CONMED CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($MN)
Table 137 CONMED CORPORATION: TOTAL REVENUE, BY REGION, (2011-2013) ($MN)
Table 138 COVIDIEN PLC: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 139 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN)
Table 140 COVIDIEN PLC: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 141 ETHICON ENDO-SURGERY, INC.: TOTAL REVENUE AND R&D EXPENSES 2011-2013($ BN)
Table 142 ETHICON ENDO-SURGERY, INC.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 143 ETHICON ENDO-SURGERY, INC.: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 144 ETHICON ENDO-SURGERY, INC.: GEOGRAPHICAL REVENUE, BY REGION (2011-2013) ($BN)
Table 145 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($BN)
Table 146 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($BN)
Table 147 FUJIFILM HOLDINGS CORPORATION: INFORMATION SOLUTIONS BUSINESS REVENUE (2012-2014) ($MN)
Table 148 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY REGION (2012-2014) ($BN)
Table 149 HOYA CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 150 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN)
Table 151 HOYA CORPORATION: LIFE CARE REVENUE, BY SEGMENTS (2012-2014) ($MN)
Table 152 HOYA CORPORATION: TOTAL REVENUE, BY REGION (2012-2014) ($MN)
Table 153 OLYMPUS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 154 OLYMPUS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN)
Table 155 OLYMPUS CORPORATION: TOTAL REVENUE, BY REGION (2012-2014) ($MN)
Table 156 SMITH & NEPHEW PLC: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($MN)
Table 157 SMITH &NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN)
Table 158 SMITH & NEPHEW PLC: TOTAL REVENUE, BY REGIONS (2011-2013) ($BN)
Table 159 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($MN)
Table 160 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN)
Table 161 STRYKER CORPORATION: MEDICAL SURGERY REVENUE, BY SEGMENTS (2011-2013) ($MN)
Table 162 STRYKER CORPORATION: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 1 ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($BN)
Table 2 ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATIONS, (2012-2020) ($BN)
Table 3 ENDOSCOPY GLOBAL MARKET REVENUE, BY PRODUCTS, (2012-2020) ($BN)
Table 4 ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION, (2012-2020) ($BN)
Table 5 ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 6 ARTHROSCOPY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 7 ARTHROSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 8 KNEE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 9 SHOULDER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 10 WRIST ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 11 ANKLE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 12 ELBOW ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 13 HIP ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 14 BRONCHOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 15 CARDIO-PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 16 COLONOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 17 COLONOSCOPY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 18 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 19 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 20 NASAL SINOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 21 LARYNGOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 22 OTOENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 23 TRANSNASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 24 THORACOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 25 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 26 GASTROINTESTINAL ENDOSCOPY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 27 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 28 UPPER GI ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 29 DOUBLE BALLOON ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 30 CAPSULE ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 31 ENDOSCOPIC ULTRASOUND SURGERY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 32 ENDOSCOPIC MUCOSAL RESECTION GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 33 CHROMOENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 34 GI NARROW BAND IMAGING BASED ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 35 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 36 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 37 TUBAL LIGATION & ECTOPIC PREGNANCY RELATED ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 38 ENDOSCOPIC LYSIS OF ADHESION GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 39 ENDOSCOPIC ENDOMETRIOSIS TREATMENT GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 40 HYSTERECTOMY AND OVARIAN CYSTECTOMY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 41 LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 42 LAPAROSCOPY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 43 LAPAROSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 44 ENDOSCOPIC BARIATRIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 45 CHOLECYSTECTOMY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 46 APPENDECTOMY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 47 HERNIA REPAIR LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 48 HAND ASSISTED LAPAROSCOPIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 49 OTHER LAPAROSCOPIC GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 50 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 51 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 52 HYDROCEPHALUS NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 53 COLLIOD CYST REMOVAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 54 ARACHNOID CYST FENESTRATION NEUROENDOSCOPIC GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 55 NEUROCYSTICERCOSIS NEUROENDOSCOPIC GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 56 SPINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 57 NEUROENDOSCOPIC ASSISTED SURGERIES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 58 UROLOGY ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 59 UROLOGY GLOBAL PROCEDURAL VOLUME, BY REGION (2012-2020) (MN)
Table 60 UROLOGY ENDOSCOPY GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 61 NEPHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 62 CYSTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 63 RESECTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 64 ENDOSCOPY GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 65 ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 66 ENDOSCOPES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 67 RIGID ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 68 FLEXIBLE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 69 ROBOT ASSISTED ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 70 CAPSULE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 71 VISUALIZATION AND DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 72 VISUALIZATION AND DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 73 ENDOSCOPIC CAMERAS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 74 DIGITAL DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 75 LIGHT SOURCES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 76 MONITORS AND DISPLAY SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 77 VIDEO CONVERTORS AND PROCESSORS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 78 FLUID MANAGEMENT SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 79 ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 80 ENDOSCOPY SERVICES GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($BN)
Table 81 GLOBAL ENDOSCOPY MARKET, BY REGION, (2012–2020) ($BN)
Table 82 ENDOSCOPY NORTH AMERICAN MARKET REVENUE, BY APPLICATION, (2012–2020) ($BN)
Table 83 ARTHROSCOPY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 84 LAPAROSCOPY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 85 UROLOGY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 86 ENT ENDOSCOPY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 87 GASTROINTESTENAL NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020)($BN)
Table 88 GYNECOLOGY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 89 NEUROLOGY NORTH AMERICAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 90 ENDOSCOPY NORTH AMERICAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 91 ENDOSCOPES NORTH AMERICAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 92 VISUALIZATION AND DOCUMENTATION SYSTEMS NORTH AMERICAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 93 ENDOSCOPY EUROPEAN MARKET, REVENUE BY APPLICATION, (2012–2020) ($BN)
Table 94 ARTHROSCOPY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 95 LAPAROSCOPY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 96 UROLOGY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 97 ENT ENDOSCOPY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 98 GASTROINTESTENAL EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 99 GYNECOLOGY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 100 NEUROLOGY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 101 ENDOSCOPY EUROPEAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 102 ENDOSCOPES EUROPEAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 103 VISUALIZATION AND DOCUMENTATION SYSTEMS EUROPEAN MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 104 ENDOSCOPY APAC MARKET, REVENUE BY APPLICATION, (2012–2020) ($BN)
Table 105 ARTHROSCOPY APAC MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 106 LAPAROSCOPY APAC MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 107 UROLOGY EUROPEAN MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 108 ENT ENDOSCOPY APAC MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 109 GASTROINTESTENAL APAC MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 110 GYNECOLOGY APAC MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 111 NEUROLOGY APAC MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 112 ENDOSCOPY APAC MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 113 ENDOSCOPES APAC MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 114 VISUALIZATION AND DOCUMENTATION SYSTEMS APAC MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 115 ENDOSCOPY ROW MARKET, REVENUE BY APPLICATION, (2012–2020) ($BN)
Table 116 ARTHROSCOPY ROW MARKET REVENUE, BY APPLICATION TYPE (2012–2020) ($BN)
Table 117 LAPAROSCOPY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 118 UROLOGY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 119 ENT ENDOSCOPY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 120 GASTROINTESTENAL ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 121 GYNAECOLOGY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 122 NEUROLOGY ROW MARKET REVENUE, BY APPLICATION TYPE (2012-2020) ($BN)
Table 123 ENDOSCOPY ROW MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 124 ENDOSCOPES ROW MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 125 VISUALIZATION AND DOCUMENTATION SYSTEMS ROW MARKET REVENUE, BY PRODUCT TYPE (2012-2020) ($BN)
Table 126 NEW PRODUCT LAUNCHES (2011-2014)
Table 127 MERGERS AND ACQUISITIONS (2011-2014)
Table 128 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2011-2014)
Table 129 APPROVALS, (2011-2014)
Table 130 OTHER DEVELOPMENTS (2011-2014)
Table 131 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 132 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN)
Table 133 BOSTON SCIENTIFIC CORPORATION: MEDICAL SURGERY BUSINESS REVENUE (2011-2013) ($MN)
Table 134 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 135 CONMED CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 136 CONMED CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($MN)
Table 137 CONMED CORPORATION: TOTAL REVENUE, BY REGION, (2011-2013) ($MN)
Table 138 COVIDIEN PLC: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 139 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN)
Table 140 COVIDIEN PLC: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 141 ETHICON ENDO-SURGERY, INC.: TOTAL REVENUE AND R&D EXPENSES 2011-2013($ BN)
Table 142 ETHICON ENDO-SURGERY, INC.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 143 ETHICON ENDO-SURGERY, INC.: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 144 ETHICON ENDO-SURGERY, INC.: GEOGRAPHICAL REVENUE, BY REGION (2011-2013) ($BN)
Table 145 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($BN)
Table 146 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($BN)
Table 147 FUJIFILM HOLDINGS CORPORATION: INFORMATION SOLUTIONS BUSINESS REVENUE (2012-2014) ($MN)
Table 148 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY REGION (2012-2014) ($BN)
Table 149 HOYA CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 150 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN)
Table 151 HOYA CORPORATION: LIFE CARE REVENUE, BY SEGMENTS (2012-2014) ($MN)
Table 152 HOYA CORPORATION: TOTAL REVENUE, BY REGION (2012-2014) ($MN)
Table 153 OLYMPUS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 154 OLYMPUS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN)
Table 155 OLYMPUS CORPORATION: TOTAL REVENUE, BY REGION (2012-2014) ($MN)
Table 156 SMITH & NEPHEW PLC: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($MN)
Table 157 SMITH &NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN)
Table 158 SMITH & NEPHEW PLC: TOTAL REVENUE, BY REGIONS (2011-2013) ($BN)
Table 159 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($MN)
Table 160 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN)
Table 161 STRYKER CORPORATION: MEDICAL SURGERY REVENUE, BY SEGMENTS (2011-2013) ($MN)
Table 162 STRYKER CORPORATION: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
LIST OF FIGURES
Figure 1 GLOBAL ENDOSCOPY MARKET SHARE, BY REGION (2012-2020)
Figure 2 ENDOSCOPY DEVICES MARKET: RESEARCH APPROACH
Figure 3 ENDOSCOPY DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 ENDOSCOPY DEVICES MARKET: FORECASTING MODEL
Figure 5 ENDOSCOPY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 ENDOSCOPY DEVICES GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 ENDOSCOPY DEVICES MARKET: PORTER’S ANALYSIS
Figure 9 GLOBAL ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013
Figure 10 GLOBAL ENDOSCOPY MARKET SHARE, BY APPLICATIONS, (2013)
Figure 11 GLOBAL ARTHROSCOPY APPLICATIONS MARKET SHARE, BY TYPE (2013)
Figure 12 GLOBAL ENT APPLICATIONS MARKET REVENUE, BY TYPE ($BILLION) (2013)
Figure 13 GLOBAL GI ENDOSCOPY APPLICATIONS MARKET SHARE, BY TYPE (2013)
Figure 14 GLOBAL GYNECOLOGY/OBSTETRICS APPLICATIONS MARKET SHARE, BY TYPE (2013)
Figure 15 GLOBAL LAPAROSCOPY APPLICATIONS MARKET SHARE, BY TYPE (2013 V’S 2020)
Figure 16 GLOBAL NEUROLOGY APPLICATIONS MARKET SHARE, BY TYPE (2013)
Figure 17 GLOBAL UROLOGY ENDOSCOPY APPLICATIONS MARKET REVENUE, BY TYPE ($BILLION) (2013)
Figure 18 GLOBAL ENDOSCOPY PRODUCTS MARKET REVENUE, BY TYPE (2013 V’S 2020)
Figure 19 GLOBAL ENDOSCOPE PRODUCTS MARKET SHARE, BY TYPE (2013 V’S 2020)
Figure 20 GLOBAL VISUALIZATION AND DOCUMENTATION SYSTEMS MARKET SHARE, BY TYPE (2013 V’S 2020)
Figure 21 GLOBAL ENDOSCOPY MARKET SHARE, BY REGION (2012-2020)
Figure 22 NORTH AMERICAN ENDOSCOPY MARKET SHARE, BY APPLICATIONS (2012-2020)
Figure 23 KEY GROWTH STRATEGIES, (2011-2014)
Figure 24 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 25 SWOT: CONMED CORPORATION
Figure 26 SWOT: COVIDIEN PLC
Figure 27 SWOT: ETHICON ENDOSURGERY, INC.
Figure 28 SWOT: FUJIFILM HOLDINGS CORPORATION
Figure 29 SWOT: HOYA CORPORATION
Figure 30 SWOT: KARL STORZ GMBH & CO. KG
Figure 31 SWOT: OLYMPUS CORPORATION
Figure 32 SWOT: SMITH & NEPHEW PLC
Figure 33 SWOT: STRYKER CORPORATION
Figure 1 GLOBAL ENDOSCOPY MARKET SHARE, BY REGION (2012-2020)
Figure 2 ENDOSCOPY DEVICES MARKET: RESEARCH APPROACH
Figure 3 ENDOSCOPY DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 ENDOSCOPY DEVICES MARKET: FORECASTING MODEL
Figure 5 ENDOSCOPY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 ENDOSCOPY DEVICES GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 ENDOSCOPY DEVICES MARKET: PORTER’S ANALYSIS
Figure 9 GLOBAL ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013
Figure 10 GLOBAL ENDOSCOPY MARKET SHARE, BY APPLICATIONS, (2013)
Figure 11 GLOBAL ARTHROSCOPY APPLICATIONS MARKET SHARE, BY TYPE (2013)
Figure 12 GLOBAL ENT APPLICATIONS MARKET REVENUE, BY TYPE ($BILLION) (2013)
Figure 13 GLOBAL GI ENDOSCOPY APPLICATIONS MARKET SHARE, BY TYPE (2013)
Figure 14 GLOBAL GYNECOLOGY/OBSTETRICS APPLICATIONS MARKET SHARE, BY TYPE (2013)
Figure 15 GLOBAL LAPAROSCOPY APPLICATIONS MARKET SHARE, BY TYPE (2013 V’S 2020)
Figure 16 GLOBAL NEUROLOGY APPLICATIONS MARKET SHARE, BY TYPE (2013)
Figure 17 GLOBAL UROLOGY ENDOSCOPY APPLICATIONS MARKET REVENUE, BY TYPE ($BILLION) (2013)
Figure 18 GLOBAL ENDOSCOPY PRODUCTS MARKET REVENUE, BY TYPE (2013 V’S 2020)
Figure 19 GLOBAL ENDOSCOPE PRODUCTS MARKET SHARE, BY TYPE (2013 V’S 2020)
Figure 20 GLOBAL VISUALIZATION AND DOCUMENTATION SYSTEMS MARKET SHARE, BY TYPE (2013 V’S 2020)
Figure 21 GLOBAL ENDOSCOPY MARKET SHARE, BY REGION (2012-2020)
Figure 22 NORTH AMERICAN ENDOSCOPY MARKET SHARE, BY APPLICATIONS (2012-2020)
Figure 23 KEY GROWTH STRATEGIES, (2011-2014)
Figure 24 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 25 SWOT: CONMED CORPORATION
Figure 26 SWOT: COVIDIEN PLC
Figure 27 SWOT: ETHICON ENDOSURGERY, INC.
Figure 28 SWOT: FUJIFILM HOLDINGS CORPORATION
Figure 29 SWOT: HOYA CORPORATION
Figure 30 SWOT: KARL STORZ GMBH & CO. KG
Figure 31 SWOT: OLYMPUS CORPORATION
Figure 32 SWOT: SMITH & NEPHEW PLC
Figure 33 SWOT: STRYKER CORPORATION
